A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma

Asthma Clinical Trial

— MODELS  

Official title:

A Comparison of Diagnostic Testing Modalities in the Assessment of Asthma

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06286085
• Other study ID #: 337788
• Status: Recruiting
• Start date: February 27, 2024
• Est. completion date: July 24, 2024

Study information

• Verified date: April 2024
• Source: Portsmouth Hospitals NHS Trust
• Contact: celia Selvin-Premkumar
• Phone: 02392 286000
• Email: celia.selvin-premkumar[@]porthosp.nhs.uk
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to assess the concordance of international asthma guidelines in the diagnosis of asthma and explore the presence of airways disease using additional non-guideline physiologic criteria, such as IOS (impulse osciollometry), not included in the guidelines, but available in the Portsmouth lung function service.

Description:

Asthma is a widespread condition that affects millions of people worldwide. It is characterized by symptoms such as difficulty breathing, coughing, and wheezing. Diagnosing asthma involves identifying certain indicators like airflow obstruction, airway sensitivity, and inflammation. However, different international guidelines, including those from organizations such as NICE (National Institute for Health and Care Excellence), GINA (Global Initiative for Asthma), and BTS (British Thoracic Society)/SIGN (Scottish Intercollegiate Guidelines Network), have varying criteria for diagnosis. This can lead to inconsistencies in identifying patients with asthma. This study aims to evaluate the effectiveness of different diagnostic approaches, including impulse oscillometry (IOS), in diagnosing asthma. IOS is a simple and non-invasive test that measures lung function. It has the potential to enhance the accuracy and ease of asthma diagnosis. Despite its promise, current research on the role of IOS in diagnosing asthma in adults is limited. To address these gaps in knowledge, the study will examine the data of patients attending the severe asthma service at Queen Alexandra Hospital in Portsmouth. With an "opt-out" consent process, routine outpatient lung function data will be analysed, paying special attention to the usefulness of IOS compared to other lung function indices in diagnosing asthma. By conducting this study, the aim is to contribute valuable insights to the field of asthma diagnosis. The study findings may help refine the methodology of diagnosing asthma and potentially expand the diagnostic toolkit to include IOS. This could improve the precision and ease of managing asthma, leading to better outcomes for patients.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 750
• Est. completion date: July 24, 2024
• Est. primary completion date: April 24, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• The patient will meet all the following criteria to be considered eligible for the

study:

• Aged 18 years or over.
• All patients who have attended full asthma workups from November 2021 till date
• Willing and able to consent to use their data in this study (opt-out form or e-consent).
• Patients referred to the Portsmouth asthma service for diagnosis and further management of presumed asthma. Comorbidities are common in asthma, thus patients with co-existing conditions such as obesity, bronchiectasis or COPD will be included.

Exclusion Criteria:

• The participant may not enter the study if either of the following apply:
• Unable to comprehend the study and provide informed consent, e.g., insufficient command of English in the absence of someone who can adequately interpret.
• Patients with other primary respiratory conditions, such as ILD.

Related Conditions & MeSH terms

• Asthma

Intervention

Other:
• Lung function tests
Pulmonary function tests

Locations

Country	Name	City	State
United Kingdom	Portsmouth Hospitals University NHS Trust	Portsmouth

Sponsors (1)

Lead Sponsor	Collaborator
Portsmouth Hospitals NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	International asthma guidelines scores	To assess the levels of concordance among international asthma guidelines for the diagnosis of asthma in patients referred to a secondary/tertiary care asthma service.	during study analysis 4 weeks after recruitment
Primary	non-guideline physiologic criteria	Assess the presence or absence of airway disease by the non-guideline physiologic criteria with those fulfilling (or not) the diagnostic criteria for asthma according to any of the selected guidelines.	during study analysis 4 weeks after recruitment
Secondary	non-guideline physiologic criteria for asthma.	Compare the clinical characteristics of patients stratified by the presence or absence of guideline and non-guideline physiologic criteria for asthma.	during study analysis 4 weeks after recruitment
Secondary	Comparison of the diagnostic outcomes of each guideline with a "reference standard".	Assess the sensitivity of each guideline in the diagnosis of airway disease by comparing the diagnostic outcomes of each guideline with a "reference standard".	during study analysis 4 weeks after recruitment